VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

<< Previous

Bullboard Posts

Next >>

Post by Jennifer2020on Nov 22, 2021 7:28am

191 Views

Post# 34151855

Financials due by Nov 30 on SEDAR

I don't anticipate any surprises or much price action over them.
December a mystery, January we could make history.
Buying all I can before GEHC launch and probable buyout.
With the Pfizer pill 90% effective and coming soon and the children's vaccine approved COVID 19 can finally be controlled IMO. Final flippingly we can switch from pandemic to endemic in treating C19. We can get our lives back and VPT can start selling and installing units. $1 plus by Jan if all goes well. GLTA

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages